SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021605
Filing Date
2022-11-03
Accepted
2022-11-03 09:17:11
Documents
50
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kura-20220930.htm   iXBRL 10-Q 2636760
2 EX-31.1 kura-ex31_1.htm EX-31.1 14091
3 EX-32.1 kura-ex32_1.htm EX-32.1 12089
  Complete submission text file 0000950170-22-021605.txt   7451383

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kura-20220930_cal.xml EX-101.CAL 41175
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kura-20220930.xsd EX-101.SCH 31225
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kura-20220930_def.xml EX-101.DEF 102305
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kura-20220930_pre.xml EX-101.PRE 202866
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kura-20220930_lab.xml EX-101.LAB 306098
44 EXTRACTED XBRL INSTANCE DOCUMENT kura-20220930_htm.xml XML 1393848
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 221356497
SIC: 2834 Pharmaceutical Preparations